Notice2022-01848
Meeting of the Advisory Committee on Childhood Vaccines
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 31, 2022
Issuing agencies
Health and Human Services DepartmentHealth Resources and Services Administration
Abstract
In accordance with the Federal Advisory Committee Act, this notice announces that the Advisory Commission on Childhood Vaccines (ACCV) will hold public meetings for the 2022 calendar year (CY). Information about the ACCV, agendas, and materials for these meetings can be found on the ACCV website at https://www.hrsa.gov/advisory- committees/vaccines/index.html.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 20 (Monday, January 31, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 20 (Monday, January 31, 2022)]
[Notices]
[Page 4898]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-01848]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the Advisory Committee on Childhood Vaccines
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Advisory Commission on Childhood Vaccines
(ACCV) will hold public meetings for the 2022 calendar year (CY).
Information about the ACCV, agendas, and materials for these meetings
can be found on the ACCV website at <a href="https://www.hrsa.gov/advisory-committees/vaccines/index.html">https://www.hrsa.gov/advisory-committees/vaccines/index.html</a>.
DATES: ACCV meetings will be held on:
<bullet> March 3, 2022, 10:00 a.m. Eastern Time (ET)-4:00 p.m. ET;
<bullet> June 2, 2022, 10:00 a.m. ET-4:00 p.m. ET;
<bullet> September 1, 2022, 10:00 a.m. ET-4:00 p.m. ET; and
<bullet> December 1, 2022, 10:00 a.m. ET-4:00 p.m. ET.
ADDRESSES: Meetings may be held in-person or virtually. For updates on
how the meeting will be held, visit the ACCV website 30 business days
before the meeting date, where instructions for joining meetings either
in-person or remotely will be posted. In-person ACCV meetings will be
held at 5600 Fishers Lane, Rockville, Maryland 20857. For meeting
information updates, go to the ACCV website meeting page at <a href="https://www.hrsa.gov/advisory-committees/vaccines/meetings.html">https://www.hrsa.gov/advisory-committees/vaccines/meetings.html</a>.
FOR FURTHER INFORMATION CONTACT: Annie Herzog, Division of Injury
Compensation Programs, HRSA, 5600 Fishers Lane, 08N186B, Rockville,
Maryland 20857; 301-443-6634; or <a href="/cdn-cgi/l/email-protection#85c4c6c6d3c5cdd7d6c4abe2eaf3"><span class="__cf_email__" data-cfemail="0647454550464e54554728616970">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The ACCV provides advice and recommendations
to the Secretary of HHS on policy, program development, and other
issues related to the implementation of the National Vaccine Injury
Compensation Program and concerning other matters as described under
section 2119 of the Public Health Service Act (42 U.S.C. 300aa-19).
Since priorities dictate meeting times, be advised that times and
agenda items are subject to change. Refer to the ACCV website listed
above for any meeting updates that may occur. For CY 2022 meetings,
agenda items may include, but are not limited to: Updates from the
Division of Injury Compensation Programs, Department of Justice, Office
of Infectious Disease and HIV/AIDS Policy (HHS), Immunization Safety
Office (Centers for Disease Control and Prevention), National Institute
of Allergy and Infectious Diseases (National Institutes of Health) and
Center for Biologics, Evaluation and Research (Food and Drug
Administration). Refer to the ACCV website listed above for all current
and updated information concerning the CY 2022 ACCV meetings, including
draft agendas and meeting materials posted 5 calendar days before the
meeting(s).
Members of the public will have the opportunity to provide
comments. Public participants may submit written statements in advance
of the scheduled meeting(s). Oral comments will be honored in the
requested order and may be limited as time allows. Requests to submit a
written statement or make oral comments to ACCV should be sent to Annie
Herzog using the contact information above at least 5 business days
before the meeting date(s).
Individuals who need special assistance or another reasonable
accommodation should notify Annie Herzog using the contact information
listed above at least 10 business days before the meeting(s) they wish
to attend. If in-person meetings occur, they will be held in a federal
government building and attendees must go through a security check to
enter the building. Non-U.S. Citizen attendees must notify HRSA of
their planned attendance at least 20 business days before the meeting
to facilitate their entry into the building. All attendees are required
to present government-issued identification before entry.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022-01848 Filed 1-28-22; 8:45 am]
BILLING CODE 4165-15-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on January 31, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.